Confluent Medical Technologies (Confluent), a leading medical device and materials science contract manufacturer specialising in Nitinol and polymer components, announces the opening of its Nitinol Wire Centre of Excellence in Hyderabad, India. This dedicated Nitinol wire manufacturing facility provides 26,000 sq ft of manufacturing space and doubles Confluent’s Nitinol wire output.

Confluent has been supplying Medical Device OEMs with Nitinol wire for over 30 years out of their Nitinol Tubing Centre of Excellence in Fremont, CA. The addition of this new facility provides a dedicated location for Nitinol wire and allows the Fremont location to focus on Nitinol tubing.

“Opening our Nitinol Wire Centre of Excellence in Hyderabad marks an important milestone in Confluent’s continued investment in a resilient, vertically integrated Nitinol supply chain,” said Dean Schauer, CEO, President, and Chairman of Confluent Medical Technologies. “This new facility expands our global manufacturing capacity and strengthens our ability to support the industry with the highest quality of Nitinol material.”

Confluent has been investing in a vertically integrated Nitinol supply chain for over 30 years, with their most recent investment being their partnership with industry melter, ATI. A manufacturing facility fully dedicated to Nitinol wire is the next step in securing an already robust Nitinol supply chain. This new facility is fully compliant with ISO 13485 standards and offers lead times of 4 weeks for wire diameter from 0.004” to 0.100” and ultra-tight tolerances down to + 0.0002”.